GlassScriptPhysician profile
Jeremy A Moore
NPI 1184707143
$3,802.15
in general payments reported to CMS, 2019-2025
19 companies · $1,304 in 2025
The $1,304 reported for 2025 was more than what 84% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $28.60 · 2021: $627 · 2022: $212 · 2023: $840 · 2024: $413 · 2025: $1,304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,556.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $889.77 | 2019-2025 | Dupixent |
| Genzyme Corporation | $547.09 | 2019-2025 | |
| Intersect Ent, INC. | $507.56 | 2019-2021 | |
| Inspire Medical Systems, INC. | $432.57 | 2023-2025 | Inspire |
| Integra Lifesciences Corporation | $348.33 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Medtronic, INC. | $325.21 | 2023-2025 | Propel, Stealthstation S8 Platform |
| Stryker Corporation | $144.21 | 2019-2025 | Core |
| Glaxosmithkline, LLC. | $142.98 | 2023-2025 | Nucala |
| Paratek Pharmaceuticals, INC. | $115.76 | 2025 | Nuzyra |
| Optinose US, INC. | $56.76 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $43.14 | 2021 | |
| Kaleo, INC. | $41.72 | 2020-2022 | |
| Hikma Pharmaceuticals USA | $34.13 | 2023-2025 | Ryaltris |
| Cook Medical LLC | $32.72 | 2021-2023 | Biodesign |
| Merck Sharp & Dohme LLC | $31.73 | 2021-2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $30.40 | 2019-2025 | |
| Arbor Pharmaceuticals, INC. | $30.13 | 2019 | |
| Aerin Medical INC. | $25.88 | 2023 | |
| Acclarent, INC | $22.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.